Abstract
In the original version of this article (1), two clonogenic assays within panel COV362 in both Figs. 2A and 6A were accidentally duplicated. The authors explained that the panels are intended to represent distinct experimental conditions and that the panels in Fig. 6A are correct. Corrected panels for Fig. 2A were provided. The corresponding graphs, as well as quantitative data, statistical comparisons, and interpretations remain valid with the revised data. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.
| Original language | English |
|---|---|
| Pages (from-to) | 198 |
| Number of pages | 1 |
| Journal | Molecular Cancer Research |
| Volume | 24 |
| Issue number | 3 |
| DOIs |
|
| State | Published - Mar 2026 |
Fingerprint
Dive into the research topics of 'Correction: GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress (Mol. Cancer Res., (2026), 24, (198))'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver